Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Molecular Analysis Tool to Improve Disease Diagnosis

By LabMedica International staff writers
Posted on 05 Nov 2025

Accurately distinguishing between similar biomolecules such as proteins is vital for biomedical research and diagnostics, yet existing analytical tools often fail to detect subtle structural or compositional variations. More...

Traditional approaches like ELISA or mass spectrometry require labeling or complex processing and can miss minute molecular differences. Now, researchers have developed a label-free analytical method called voltage-matrix nanopore profiling, which can classify biomolecules based on their intrinsic electrical signatures.

The breakthrough by researchers from The University of Tokyo (Tokyo, Japan) combines multivoltage solid-state nanopore recordings with machine learning to create a multidimensional map of molecular signals. Their research, published in Chemical Science, demonstrate how this technique can identify and classify proteins in complex mixtures without modification, paving the way for next-generation molecular diagnostics.

Solid-state nanopores act as nanoscale tunnels through which individual molecules pass, driven by ionic current. By systematically varying the voltage, the team recorded how protein molecules interacted with the nanopores under different electrical conditions. These measurements formed a voltage matrix, which captured both stable and voltage-sensitive features of each molecule. Machine learning algorithms then analyzed these features to accurately classify and distinguish proteins, even when they were mixed together.

To validate their approach, the researchers analyzed mixtures containing two cancer-related biomarkers: carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3). Using six voltage conditions, they constructed distinct signal patterns that reliably differentiated each protein. The technique also detected molecular changes when CEA bound with an aptamer—a short, synthetic DNA sequence—demonstrating its sensitivity to subtle structural alterations.

In another test using mouse serum samples, the voltage-matrix framework successfully distinguished between centrifuged and non-centrifuged sera, confirming its potential for real-world diagnostic use. The method revealed compositional differences invisible to conventional single-voltage nanopore measurements, underscoring its ability to uncover molecular diversity in complex biological fluids.

By integrating physics, nanotechnology, and artificial intelligence, this new analytical framework offers a powerful tool for understanding molecular individuality—the unique electrical signature of each molecule. It holds promise for biomedical applications ranging from disease diagnosis to environmental monitoring, providing a foundation for high-resolution, real-time molecular profiling.

“By systematically varying voltage conditions and applying machine learning, we can create a voltage matrix that reveals both robust, voltage-independent molecular features and voltage-sensitive structural changes,” said Professor Sotaro Uemura. “Our study is not simply about improving detection sensitivity — it establishes a new way to represent and classify molecular signals across voltages, allowing us to visualize molecular individuality and estimate compositions within mixtures.”

Related Links:
The University of Tokyo


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automatic CLIA Analyzer
Shine i6000
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: New findings demonstrate a blood RNA signal that may indicate ovarian cancer before conventional tests detect a tumor. (Image Credit: iStock)

Blood RNA Test May Detect Precursors to Ovarian Cancer

High-grade serous ovarian cancer is often diagnosed at an advanced stage, limiting opportunities for early intervention. The disease frequently originates in the fallopian tube as serous tubal intraepithelial... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.